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Infertility in men and women is a complex genetic trait with shared biological bases between
the sexes. Here, we perform a series of rare variant analyses across 73,185 women and men
to identify genes that contribute to primary gonadal dysfunction. We report CSMD1, a
complement regulatory protein on chromosome 8p23, as a strong candidate locus in both
sexes. We show that CSMD1 is enriched at the germ-cell/somatic-cell interface in both male
and female gonads. Csmd1-knockout males show increased rates of infertility with sig-
niﬁcantly increased complement C3 protein deposition in the testes, accompanied by severe
histological degeneration. Knockout females show signiﬁcant reduction in ovarian quality and
breeding success, as well as mammary branching impairment. Double knockout of Csmd1 and
C3 causes non-additive reduction in breeding success, suggesting that CSMD1 and the
complement pathway play an important role in the normal postnatal development of the
gonads in both sexes.
https://doi.org/10.1038/s41467-019-12522-w OPEN
1 Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA. 2 Estonian Genome Center, University of Tartu, 51010 Tartu,
Estonia. 3 Oregon National Primate Center, Oregon Health and Science University, Beaverton, OR 97006, USA. 4Department of Pharmaceutical Sciences,
Southern Illinois University, Edwardsville, IL 62025, USA. 5Division of Rheumatology, Department of Medicine, Washington University School of Medicine,
St. Louis, MO 63110, USA. 6Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT 84132, USA. 7 College of Veterinary Medicine,
University of Illinois, Urbana-Champaign, IL 61802, USA. 8 The School of Biological Sciences, Monash University, Clayton, Victoria 3800, Australia.
9 Department of Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, OR 97239, USA. *email: conradon@ohsu.edu









The human genetic study of infertility has historically clas-siﬁed male infertility and female infertility as distinct dis-eases, leading to the assembly of many separate cohorts for
the study of sex-speciﬁc reproductive processes1–4. However,
numerous molecular and physiological mechanisms of fertility
regulation are shared between male and female mammals5. For
instance, programmed germ cell degeneration is a pervasive part
of gonadal biology in both sexes6,7. In human males, roughly 80%
of the meiotic descendants of spermatogonial stem cells undergo
apoptosis prior to ever becoming mature spermatozoa8. Likewise,
human females are born with ~500,000 oocytes and ovulate
roughly 400 times after menarche. However, only roughly 1000
oocytes survive the sojourn to menopause, representing colossal
germ cell loss not attributable to ovulation9. This ratio of sur-
viving:apoptotic germ cells differs between species, but is nar-
rowly maintained within species8,10. The principles that govern
the loss versus survival of given germ cells are poorly understood.
Defects in germ cell development intrinsic to the gonad are
deﬁned as primary gonadal dysfunction. Primary gonadal dys-
function — which manifests as early idiopathic menopause in
women and oligo-/azoo-spermia in men — is a subset of the
infertility phenotype that is tractable for human genetic analysis
and has a prevalence of at least 1% in adult males and
females11,12. We previously identiﬁed a reproducible association
between rare copy number variant (CNV) burden and oligo-
spermia and azoo-spermia in men13,14. One of several candidate
loci from this study included the complement regulatory CUB
and Sushi multiple domains 1 (CSMD1) gene.
The primary protein sequence of CSMD1 shares homology
with complement-interacting proteins15. Complement acts as an
inﬂammatory/phagocytic signal in the innate immune system16,
and previous work has shown that classical complement com-
ponents C1q and C3 are also responsible for microglia-mediated
phagocytosis of excess neuronal cells in a normal post-natal
developmental process known as synaptic pruning17. Common
variants in CSMD1 (refs. 18,19) and complement C4 (ref. 20) have
also been associated with schizophrenia in independent, well-
powered human association studies. Furthermore, some of the
most signiﬁcantly associated variants previously associated with
azoospermia include the greater MHC locus, which encompasses
complement C2, C4, and factor B21,22. CSMD1 is also known to
inhibit the classical complement pathway in vitro15,23.
In this study, we incorporate array and exome sequencing data
from a large cohort of early idiopathic menopause from the
Women’s Health Initiative24 to search for novel, shared factors
required for normal gonadal function in both sexes, identifying
an association with the gene CSMD1 in male and female gonadal
dysfunction, and replicate our ﬁndings with samples from the UK
Biobank25. We characterize the expression patterns of CSMD1 in
female and male gonads and measure morphological and repro-
ductive traits in Csmd1-knockout mice, thereby adding a level of
functional support to our genetic ﬁndings. Finally, to consolidate
the putative roles of complement with Csmd1-mediated pathol-
ogy, we investigate the in situ abundance of macrophages and
complement component C3 in Csmd1-wildtype versus Csmd1-
null tissues. Our ﬁndings highlight the value of human genetic
analysis as an entry point into surprising and previously unap-
preciated pathways in disease processes — in this case, a novel
connection between of complement-related processes and gona-
dal function.
Results
CSMD1 is associated with gonadal failure in both sexes. Due to
the strong purifying selection against infertility mutations, we
hypothesized that male and female gonadal dysfunction are
driven largely by rare mutation events. To test this hypothesis, we
obtained SNP array and phenotype data from 12,002 women (515
cases of early idiopathic menopause vs. 11,487 normal menopause
controls) and 2,072 men (321 cases of oligo-spermia or azoo-
spermia vs. 1,751 normospermic controls) with documented
reproductive health history. Due to reduced linkage dis-
equilibrium between common SNPs and rare variants, we instead
leveraged the SNP log R ratios and B-allele frequencies to perform
ab initio discovery of CNVs that occupy the entire allele fre-
quency spectrum (Supplementary Data 1). We performed rigor-
ous call and sample QC with emphasis on high conﬁdence calls
based on established methods (see Methods section13,14,26, Sup-
plementary Fig. 1). We then applied ﬁlters to enrich for rare,
deleterious CNVs. We used these CNVs to perform a gene-based,
case-control rare variant association separately in males and
females. This approach allows for interrogation across the gen-
ome with a substantially lower multiple hypothesis burden than is
required for traditional common-variant GWAS.
Our rare variant association study identiﬁed a signiﬁcant
association between early idiopathic menopause and deletions
overlapping the CSMD1 gene located on chromosome 8p23.2
(OR= 16; PLINK nominal p-value= 4.0 × 10−4; PLINK genome-
wide p-value= 0.015; Fig. 1, Supplementary Tables 1, 2,
Supplementary Data 2). This association signal replicated in
GEMINI13, our smaller cohort of male oligo-/azoo-spermia cases
(OR= 3.3; PLINK nominal p-value= 6.5 × 10−3). This CNV
association is driven by an enrichment of rare deletions in cases,
all of which are clustered at the 5′ end of the gene within introns
1–3 (5′-deletions; Fig. 1a).
To further replicate the association between deletions in
CSMD1 and risk for gonadal dysfunction, we assembled an
independent female early idiopathic menopause case-control
cohort using the UK Biobank (see Methods section). After CNV
QC and rigorous case/control selection, we obtained a cohort of
63,064 women with both reliable phenotype data and CNV calls
(1,873 cases versus 59,947 controls). We again observed a
signiﬁcant association between early menopause and rare 5′-
deletions of CSMD1 (OR= 3.03, logistic regression p-value < 5 ×
10−4, Fig. 1a, b). To summarize the overall risk conferred by rare
CSMD1 5′-deletions of all sizes, we performed a meta-analysis
across all three cohorts (OR= 3.6 95% CI [2.14−6.01]; meta-
analysis logistic regression p-value= 1.2 × 10−6; Fig. 1c; Supple-
mentary Table 1).
We further tested our association using genotypes ascertained
by an orthogonal genotyping modality, by analyzing rare (MAF <
0.01) CSMD1 single nucleotide variants (SNVs) from exome
sequencing performed on a subset of the WHI cohort (n= 1526).
We performed a single-locus quantitative trait analysis and found
a statistically signiﬁcant association between rare, deleterious
CSMD1 SNVs and age at menopause (SKAT single-locus p-value
< 5 × 10−3; Fig. 1, see Methods section). The CSMD1 protein
product consists almost entirely of alternating/repeating CUB
(complement C1r/C1s, Uegf, Bmp1) and Sushi/CCP (comple-
ment control protein) domains (Fig. 2a). Thus, in order to assess
the relative contribution of in CUB versus Sushi domain SNVs to
age at menopause, we ﬁt linear models to partition the association
signal among these two domains. The CSMD1 SNV association
was driven almost exclusively by mutations in the CUB (βCUB=
−0.86), but not Sushi (βSUSHI= 0.046) domains (Wilcoxon rank-
sum test p-value= 0.043; Fig. 1d, see Methods section). Our
regression model estimates that each CUB domain SNV
accelerates the onset of menopause by ~10 months. Finally, a
well-powered common variant GWAS in a female cohort of
182,416 individuals identiﬁed 3 common SNPs within CSMD1 to
be signiﬁcantly and independently associated with age at
menarche and subsequently replicated in >300,000
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individuals27,28 (Fig. 1). Subsequent work in the same cohort
showed age of menarche and menopause to be positively
correlated. Furthermore, the common CSMD1 SNPs associated
with age of menarche also correctly predicted age of menopause
in the expected direction (βrs2688325= 0.014; βrs7828501= 0.021;
βrs7463166= 0.031)29.
The phenotype of idiopathic early menopause indicates
problems in ovarian function. Predictable consequences of such
ovarian dysfunction are irregular or absent menses and reduced
fecundity. To further clarify the role of CSMD1 deletions in
female reproductive traits, we tested for association with 4
additional reproductive phenotypes available from the UKBB (see
Methods section). Of these traits, we identiﬁed a signiﬁcant
association with age at last live birth (n= 76,686, linear regression
p-value= 4.1 × 10−3, Fig. 1e). Individuals with CSMD1 deletions
show a reduced reproductive lifespan across all quartiles of the
cumulative distribution, corresponding to an average reduction of
1 year. To compare relative effect sizes, our ﬁtted model predicts
that obesity status reduces reproductive lifespan by 0.6 years, and
smoking status reduces reproductive lifespan by 1 year (see
Methods section). The maximum age at last birth among our
controls is 51 years, versus 40 years for CSMD1 deletion carriers.
However, we note that 99.6% of control individuals have
completed childbearing by age 36, indicating that traditional
measures of fertility (e.g. fecundity) would not necessarily capture
ovarian dysfunction related to CSMD1 deletions.
In summary, we detected associations between rare variants in
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Fig. 1 Genetic variants in CSMD1 are associated with primary gonadal dysfunction. a The landscape of genetic variation across CSMD1 among all cohorts.
SHARE/GEMINI: rare deletions overlapping CSMD1 among 14,074 females and males from the SHARE and GEMINI cohorts; UKBB: rare intron 1–3
deletions observed in 63,064 females from the UK Biobank early idiopathic menopause cohort — for clarity of visualization only the deletions observed in
cases are shown; WHISP: 37 rare SNVs overlapping CSMD1 among 1,526 exome-sequenced females; and Day et al.: three statistically independent lead
SNPs from a large-scale GWAS of age at menarche in females are depicted as points along the bottom of the ﬁgure (left to right): rs2688326, rs2724961,
and rs487542428. All coordinates are in hg19. b Summary of the human genetic evidence that CSMD1 variants are associated with gonadal function in men
and women described in this study. c Stacked barplot depicting frequency of rare CNVs overlapping introns 1–3 of CSMD1 among 2,709 cases of male or
female gonadal dysfunction versus 73,185 controls. Rare deletions over CSMD1 segregate signiﬁcantly with cases (odds ratio= 3.6; meta-analysis logistic
regression p-value= 1.2 × 10−6). d Density plots depicting effect sizes (β) of rare CSMD1 SNVs on age at menopause for synonymous (blue) and
nonsynonymous (red) SNVs, stratiﬁed by protein domain (CUB vs. Sushi). SNVs in the CUB domains are signiﬁcantly associated with an earlier onset of
menopause when compared to SNVs in the Sushi domains (βCUB=−0.86, 95% CI [−1.56, −0.151]; βSUSHI= 0.046, 95% CI [−0.255, 0.377]; Wilcoxon
rank-sum test p-value= 0.043). Synonymous mutations in both CUB and Sushi domains are centered about 0, consistent with a well-calibrated estimate
of effect size. e The cumulative distribution of age at last birth in UK Biobank subjects, plotted separately by CSMD1 deletion status. There is a 1-year
reduction in the mean age at last birth for women with deletions in introns 1–3 of CSMD1 compared to women without deletions (linear regression
p-value= 4.1 × 10−3). Source data are provided as a Source Data ﬁle
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genetic variation; (ii) ascertained by orthogonal genotyping
platforms; (iii) occupying multiple points along the allele
frequency spectrum; and (iv) in multiple populations and cohorts.
Detailed CSMD1 expression patterns in male and female
gonads. CSMD1 encodes for an extremely large (>3,000 amino
acid) transmembrane protein with a large extracellular portion
consisting of alternating CUB and Sushi complement-interacting
domains15. The protein encoded by CSMD1 is conserved between
human and mouse, with 93% amino acid sequence identity and
100% domain synteny (Fig. 2a). In humans, CSMD1 is expressed
in both male and female gonads (Supplementary Fig. 2), but
extremely little is known of its molecular function, particularly in






































































Fig. 2 Csmd1 is expressed in the male and female gonads. a Protein model of CSMD1 in human and mouse. CUB and Sushi domains, as well as the
transmembrane and cytosolic domains are depicted along the protein model (97.1% of the CSMD1 protein is extracellular). b RNA expression of mouse
Csmd1 in sexually immature whole testes (20 days), sexually mature whole testes (40 days), and whole ovary. RNA-seq of FACS-puriﬁed germ cell
populations show Csmd1 expression changes during spermatogenesis. Csmd1 RNA is maximally expressed at the spermatid period of development. Boxplot
center line=median; hinges= upper and lower quartiles; whiskers= 1.5 × interquartile range. Line chart error bars reﬂect standard error of the mean.
c CSMD1 protein immunoﬂuorescence in developing oocytes (marked by MVH) and surrounding somatic cells. MVH expression decreases, whereas
CSMD1 expression increases with follicular development. CSMD1 encircles the oocytes at all follicle stages. Follicles named in each box are marked with
white arrows when necessary. Theca cells are indicated by stars. d CSMD1 is maximally expressed at the oocyte surface and extends into the transzonal
projections (white arrowheads), which physically connect the germ cell to the surrounding somatic granulosa cells (left). During ovulation the follicle
releases the oocyte and regresses to form the corpus luteum (dashed lines). CSMD1 signal is absent. An oocyte is highlighted for comparison (white
arrowhead, right). e Immunoﬂuorescence (IF) visualization of CSMD1 (red) in testis seminiferous tubule cross sections (x–y axis). CSMD1 protein is
broadly expressed in germ cells across all stages of spermatogenesis. MVH is a primordial germ cell marker whose expression peaks early, then steadily
decreases during spermatogenesis/oogenesis. CSMD1 is maximally expressed in elongating spermatids (white arrowheads). f Whole mount testis tubule
preparation (z axis). F480-positive macrophages (green) with characteristic ramiﬁed processes occupy the longitudinal interstitial space. CSMD1 (red) is
expressed in a hatched pattern which may correspond to the actin cytoskeleton of peritubular myoid cells and Sertoli cells. Four Sertoli cells surrounding a
macrophage outlined by dotted lines. All scale bars= 50 μm. Source data are provided as a Source Data ﬁle
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mouse gonads and conﬁrmed that Csmd1 mRNA is expressed in
both whole ovaries and whole testes (Fig. 2b, Supplementary
Fig. 3), consistent with previous work30,31. Next, we detailed
patterns of in situ CSMD1 protein expression through the dif-
ferent stages of ovulation using a validated CSMD1 antibody
(Supplementary Fig. 4). Throughout oogenesis, CSMD1 shows
lower expression in oocytes of early follicles (i.e. primordial and
primary follicles) and higher expression in oocytes of late follicles
(i.e. secondary, tertiary, and pre-ovulatory follicles; Fig. 2c).
Supporting theca cells, which circumscribe the mature follicles,
are also CSMD1-positive (Fig. 2c, asterisk). The post-ovulatory
corpus luteum shows no speciﬁc CSMD1 expression (Fig. 2d).
Female oocytes require substantial physical interaction with
surrounding somatic cells32. At high magniﬁcation, CSMD1 is
expressed along transzonal projections which connect the somatic
granulosa cells to the oocyte membrane (Fig. 2d).
In the testes, Csmd1 mRNA is minimally expressed at 20 days
and more robustly expressed at 40 days of age which coincides
with the onset of sexual maturity. Mammalian testes demonstrate
exceptional transcriptional complexity, owing to the highly
coordinated spatial and temporal synchronization required for
successful spermatogenesis throughout male adult life30. There-
fore, to capture a more detailed transcriptional portrait of Csmd1
in testes, we puriﬁed germ cell subpopulations using established
FACS protocols (see Methods section; Supplementary Fig. 3a).
Subsequent RNA-seq of puriﬁed germ cells reveals low levels of
Csmd1 expression in spermatogonia and primary spermatocytes
and peak expression in secondary spermatocytes and spermatids
(Fig. 2b; Supplementary Fig. 3).
We also performed immunoﬂuorescence on seminiferous
tubule cross-sections which show that CSMD1 protein is
expressed at the germ cell membrane across multiple aspects of
spermatogenesis, including at the interface of elongated sperma-
tids and somatic Sertoli cells, but is absent from spermatozoa,
recapitulating mRNA expression patterns (Fig. 2e; Supplementary
Fig. 3). While tubule cross-sections effectively capture informa-
tion from the lumenal stages of spermatogenesis, much of the
spatial variance of basal germ cells, Sertoli cells, and interstitial
cells (e.g. macrophages) occurs along the longitudinal axis33.
Therefore, we also performed immunoﬂuorescence on whole-
mount longitudinal preparations of individual seminiferous
tubules. CSMD1 is expressed in a hatched pattern which is
reminiscent of the actin bundles found at the Sertoli–Sertoli
blood–testis barrier and the Sertoli-spermatid interface34 (Fig. 2f).
Csmd1 KO causes fertility phenotypes across multiple tissues.
Association studies in humans are effective in identifying candi-
dates for disease risk. However, owing to the extensive linkage
disequilibrium structure in the human genome, even statistically
robust and reproducible associations may implicate linked but
biologically non-causal loci (sometimes up to megabase scales)35.
In order to conﬁrm a role for CSMD1 in mammalian reproduction,
we obtained a previously described mouse strain with a knockout
of the ﬁrst exon of Csmd1 (refs. 31,36) (Supplementary Fig. 4).
RNA-seq of knockout females demonstrated robust loss of Csmd1
expression in the ovaries. In testes, we observe a more complex
perturbation of expression, with absent or highly reduced expres-
sion of exons 1–57, but upregulation of exons 58–70. Finally, we
cross-referenced multiple expression modalities (RNA-seq,
CSMD1 immunoﬂuorescence, β-Gal immunoﬂuorescence, and X-
gal staining; Fig. 2; Supplementary Fig. 4) and found multiple lines
of evidence corroborating expected CSMD1 spatial patterns in
wildtype tissues. We also identiﬁed nonspeciﬁc signal in KO tis-
sues, in particular in our CSMD1 immunoﬂuorescence assay
(Supplementary Fig. 4c).
We generated a colony of Csmd1 wildtype, heterozygous, and
knockout mice and observed the effect of genotype on fertility,
gonadal morphology and function in male and female mice. In
males, Csmd1 knockout leads to variable, but statistically
signiﬁcant, defects across multiple dimensions of gonad function
and fertility. First, we observed an increase in infertility rate
among knockout males (30%) compared to wildtype (4.5%)
(linear regression p-value= 4 × 10−4, Fig. 3a). Second, knockout
males show on average a 25% reduction in the daily sperm
production compared to controls (Wald test p-value= 0.029,
Fig. 3b). Third, a subset of Csmd1 knockout males suffer from
profound anatomic and histopathologic derangement of the testes
(Fig. 3c–e; Supplementary Fig. 5). Remarkably, the most severe
examples of germ cell elimination (Sertoli cell-only syndrome),
could be observed as early as 34 days of age (Fig. 3c;
Supplementary Fig. 5). This time point corresponds to the
approximate onset of male sexual maturity and the emergence of
the spermatid germ cells, where Csmd1 is maximally expressed.
Neither knockout nor wildtype testes showed evidence of
derangement prior to sexual maturity (Supplementary Fig. 5c).
Both histologic severity (none, mild, and severe) and age of onset
(postnatal day 34 through day 300) were highly variable between
individuals. In fact, different foci within the same testis of Csmd1
knockout mice often simultaneously present different degrees of
seminiferous tubule degeneration (Fig. 3d). Finally, signiﬁcantly
fewer germ cells express the male germ cell antigen TRA98
(Poisson regression p-value < 2 × 10−16; Supplementary Fig. 5d),
in both atrophic and normal tubules, suggesting that knockout
testes suffer from expression perturbations in addition to, or
perhaps presaging, loss of germ cells and frank degeneration.
Together, these observations indicate that the Csmd1 knockout
mutation is not fully penetrant and may be inﬂuenced by
environmental and/or stochastic events. However, even after
accounting for age covariates, testes derangement status segre-
gates signiﬁcantly with Csmd1 genotype (multivariate ANOVA p-
value= 7.69 × 10−3; see Methods section; Fig. 3e). Lastly, we
performed serial backcrossing for 9 generations on a subset of
mice to validate the effect of the Csmd1 null allele on an
approximately constant genetic background (see Methods
section). We recapitulated the degeneration phenotype in these
backcrossed male knockouts (Supplementary Fig. 5e), indicating
that Csmd1 genotype status — not genetic background — drives
this signal of degeneration.
Detailed histological analysis of 50 knockout testes revealed
heterogenous and distinct classes of degeneration in Csmd1−/−
testes (Fig. 3d). Spermatogenesis begins to become disorganized,
especially at the late steps of spermiogenesis, with failure of
spermiation, fewer numbers of elongating spermatids in the
lumen, and ectopic mixing of spermatid steps in stages IX–XII.
This is followed by the sloughing of all types of germ cells into the
lumen; remaining germ cells can be observed in abnormal tubules
that appear to be missing one or more waves of spermatogenesis,
and these eventually resolve as Sertoli cell-only tubules. Sloughed
germ cells can be seen downstream in the epididymis, and,
occasionally they obstruct the downstream rete testis leading to
dilation of the upstream tubules.
Three non-exclusive scenarios may account for the net loss of
germ cells in Csmd1 knockouts: (i) increased germ cell death; (ii)
failure of germ cell proliferation/maturation; and (iii) increased
phagocytic clearance of germ cells. We did not observe obvious
differences in the abundance of apoptotic germ cells apparent by
H&E staining. We excluded systemic endocrine defects that
would be observed in the case of failure of the hypothalamus or
pituitary (Supplementary Fig. 6). We also did not observe any
developmental stage-speciﬁc accumulation or depletion of germ
cells as characterized in maturation arrest/failure of meiosis37,38.
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Finally, we did not observe signiﬁcant differences in the
proliferation marker PCNA levels between Csmd1 wildtype
(9.4%) and knockout (7.0%) testes.
Complement C3 deposition is increased on Csmd1 KO testes.
FACS-puriﬁcation and RNA-seq of wildtype male germ cells show
that C3 and Csmd1 mRNA expression are negatively correlated
throughout spermatogenesis (Fig. 4a); in contrast to Csmd1, C3
mRNA is most highly expressed in spermatogonia and decreases
precipitously in subsequent stages. In wildtype testes, we observed
abundant signal of both C3 protein and macrophage marker F4/80
in the interstitial space between seminiferous tubules, but never
across the blood–testis barrier (Fig. 4b). Next, we estimated
macrophage abundance and C3 protein deposition in Csmd1
wildtype vs. knockout testes (Fig. 4c; Supplementary Fig. 7). The
percentage of C3-positive deposition is signiﬁcantly higher in
Csmd1 knockout testes than in wildtype (x̅wt= 1.7%; xk̅o= 6.6%;
ANOVA p-value= 7.7 × 10−4). C3 is a secreted, circulating pro-
tein whose mRNA is expressed by multiple cell types — including
the germ cells themselves. Therefore, we also measured C3 mRNA
expression in Csmd1 wildtype versus knockout puriﬁed male germ
cells (Fig. 4d). C3 mRNA expression does not differ between
wildtype and knockout germ cells of any type, indicating that the
germ cells are not necessarily the source of the increased C3
protein deposition.
Csmd1 KO ovaries are reduced in quality. The observed rate of
infertility in knockout females (3/37, 8.1%) was not signiﬁcantly
higher compared to controls (5/115, 4.3%, Fig. 5a). The female
infertility phenotype we ascertained in human does not likely
represent congenital infertility, but instead adult-onset early
menopause, which is difﬁcult to model in mice39. Thus, we
searched for more subtle gonadal defects associated with Csmd1
genotype. We estimated female time to pregnancy based on ret-
rospective husbandry records. From these records, we generated a
well-calibrated null distribution of time to conception in females
of all genotypes which demonstrates distinct periodicity lasting
4–5 days, recapitulating the periodicity of the mouse female
estrous cycle (Fig. 5b). Next, we stratiﬁed our population by
maternal genotype. For wildtype mothers, the bulk of conceptions
occurred within the ﬁrst estrous cycle as expected40, whereas
most Csmd1 knockout mothers required a time equivalent to two
or more cycles to achieve pregnancy (βGT= 10.4; linear regres-
sion p-value= 0.012). A small minority of knockout females
required many cycles to achieve pregnancy (>60 days). Circu-
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Fig. 3 Variable reproductive defects in Csmd1 KO males. a Barplot depicting proportions of infertile Csmd1 wildtype (WT) vs. knockout (KO) males. KO
males showed signiﬁcantly higher rate of infertility (relative risk= 6.8, linear regression p-value= 4 × 10−4). b Daily sperm production is 25% lower in
knockout testes after controlling for age (Wald test p-value= 0.029). Center line=median; hinges= upper and lower quartiles. c Seminiferous tubule
histology of wildtype vs. knockout littermates at postnatal day 34. The majority of knockout tubules in this sample contain no germ cells (Sertoli-only).
d Qualitative classes of progressive morphologic degeneration. Seminiferous tubules from Csmd1 knockout males showing normal morphology (Normal);
loss of spatiotemporal structure, but retained germ cells in all phases of spermatogenesis (Disorganized); loss of early germ cells into the tubule lumen
(Sloughing); loss of all germ cells except late-step spermatids (Missing waves); and loss of all germ cells, leaving a signature of vacuolization (Sertoli-only).
Sloughed germ cells from upstream tubules are occasionally captured in the downstream epididymis (Ectopic germ cells). Csmd1 knockout males can
display multiple classes of degeneration even within the same testis. Like the histological phenotypes, fertility status varies greatly among knockout
individuals, with some males becoming infertile within weeks, and others within months. e Quantiﬁcation of the degeneration phenotype. Testis sections
from Csmd1 wildtype and knockout animals were assigned one of three possible histological degeneration scores: None= 0, Mild= 1, or Severe= 2 (see
Methods section). The stacked barplots depict the proportion of damaged tubules among wildtypes and knockouts, stratiﬁed by age group. All proportions
sum to 1. Damage severity segregates signiﬁcantly with genotype after controlling for age (ANOVA p-value= 7.69 × 10−3). All scale bars= 50 μm. Source
data are provided as a Source Data ﬁle
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knockouts after controlling for estrous stage, suggesting that this
reduction in mating success was not secondary to impaired
hormonal input (Supplementary Fig. 6). Csmd1 knockout females
had signiﬁcantly smaller ovaries by mass when controlling for
age, (quadratic regression p-value= 8.1 × 10−3; Fig. 5c; Table 1),
and knockout females showed signiﬁcantly more atretic follicles
and fewer normal pre-ovulatory follicles at necropsy (Hotelling
t-test p-value= 3.5 × 10−3; Fig. 5d). In a subset of female
knockout ovaries, we observed inﬂammatory changes associated
with inﬁltration of lipid-engorged macrophages (foam cells) and
occasional ovarian cysts (Fig. 5e, f). Altogether, we ﬁnd that
Csmd1 knockout females display ovarian defects that are nor-
mally associated with progressive wildtype aging (i.e. smaller
ovary size41, increase in atretic follicles42, and enrichment of foam
cell macrophages43), but at signiﬁcantly accelerated rates and
higher proportions in knockouts.
C3 is abundant in follicles and colocalizes with CSMD1. In
wildtype ovaries, C3 is localized to the oocyte surface in normal
developing follicles, colocalized with CSMD1, and then observed
to be diffused in large amounts throughout the corpus luteum
(Fig. 6), which does not express CSMD1. Macrophages are a
prominent cell type in the ovarian stroma but are excluded from
early stage follicles; they later invade corpora lutea and degrading
follicles44. Furthermore, C3 colocalizes with macrophages in the
corpus luteum, atretic follicles, and among developing follicles to
variable degrees. C3 is also abundant within the early follicular
antrum, suggesting that C3 may be important for remodeling the
connections between granulosa cells during antrum formation
(Fig. 6b). Previous work has shown that activated C3 is present in
human antral follicular ﬂuid at levels comparable to sera45.
Csmd1 KO mothers have impaired mammary branching.
Interestingly, while knockout females achieved fewer pregnancies
per estrous cycle, the average number of offspring born per
successful pregnancy did not differ signiﬁcantly between wildtype
and knockout mothers (x ̅wt= 6.6 (95% CI [5.4−7.8]); x̅ko= 6.9
(95% CI [5.7−8.1]); Table 1). However, pups borne of Csmd1
knockout mothers suffered from signiﬁcantly higher mortality
rates during the neonatal period (1–10 days) when compared to
wildtype/heterozygous mothers (% mortalityWT+het= 10.5%
(95% CI [3.6−17.5%]); % mortalityKO= 50.0% (95% CI [30.0
−70.0%]); Poisson regression p-value= 7.93 × 10−7; Fig. 7a). We
performed necropsy on expired offspring which revealed an
absence of milk spots, suggesting death by starvation. Because
neonatal mortality segregated with maternal genotype but not
offspring genotype or paternal genotype, we hypothesized that
this increase in mortality was caused by nursing defects in
Csmd1-deﬁcient mothers. CSMD1 is expressed in the normal
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Fig. 4 Normal and aberrant complement C3 localization in Csmd1 wildtype versus knockout testes. a C3 mRNA expression in sexually immature whole
testes, sexually mature whole testes, and whole ovary. RNA-seq of FACS-puriﬁed germ cell populations shows C3 expression decreases throughout
spermatogenesis. Csmd1 expression data from Fig. 2 are rescaled and superimposed for ease of comparison. Line chart error bars reﬂect standard error of
the mean. b Complement and macrophages are conﬁned to the interstitial compartment in normal tubules. F4/80 immunoﬂuorescence of whole mount
tubule preparations shows abundance of macrophages along the interstitium (left). C3 immunoﬂuorescence of tubule cross-sections shows expression in
the interstitium, but not within the lumenal compartment (middle). Cross-section of downstream epididymis shows continued exclusion of C3 from the
lumenal compartment (right). Individual tubules are circumscribed by dashed lines. Scale bars= 50 μm. c Boxplots depicting F4/80 abundance and C3
protein deposition in FACS-sorted Csmd1 wildtype vs. knockout testes. Both F4/80 and C3 are increased in Csmd1 knockout testes, though only signiﬁcant
for C3 (ANOVA p-value= 7.7 × 10−4). d RNA-seq of Csmd1 wildtype vs. knockout germ cell populations shows no signiﬁcant difference in C3 mRNA
expression (two-tailed t-test; p-value > 0.05). For all boxplots, center line=median; hinges= upper and lower quartiles; whiskers= 1.5 × interquartile
range. Source data are provided as a Source Data ﬁle
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on both lumenal epithelial cells and myoepithelial cells of the
mammary ducts, and on numerous stromal cells (Fig. 7b, c).
Mammary glands from knockout females showed reduced density
of the epithelial branching network during mid-pregnancy and
post-nursing (Fig. 7d). Quantiﬁcation of duct morphology in
nulliparous wild type and knockout animals shows a signiﬁcant
reduction of lateral branching prior to pregnancy (Fig. 7e, f).
Finally, we measured C3 and CSMD1 expression patterns in
wildtype mammary glands (Fig. 7g). As early as puberty, C3 can
be seen in high levels within the mammary duct lumen of virgin
animals. C3 is also expressed within vesicles of speciﬁc subsets of
CSMD1-positive stromal cells (Fig. 7g).
Csmd1−/− C3−/− double KO males and females are infertile.
Based on previous ﬁndings that CSMD1 is a negative regulator of
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Fig. 5 Csmd1 knockout ovaries show reduced morphologic quality and reproductive performance. a Barplot depicting proportions of infertile Csmd1 wildtype
(WT) vs. knockout (KO) females. In the population sampled (n= 115 WT+ 40 KO), Csmd1 genotype does not signiﬁcantly predict infertility status in
females (relative risk= 1.9, linear regression p-value > 0.05). b Probability density plot depicting female mating success over time, stratiﬁed by maternal
genotype (black=wildtype females; red= knockout females; gray= all females). The distribution is periodic, recapitulating the periodicity of the mouse
female estrous cycle. Knockout females require signiﬁcantly more cycles to achieve pregnancy (βGT= 10.4, linear regression p-value= 0.01), with a small
subset of females never achieving pregnancy. All statistical models account for confounders such as age, body weight, and male factors when appropriate
(see Methods section). c Scatterplot depicting ovary weight versus age, stratiﬁed by genotype (black=wildtype females; red= knockout females). The
ﬁtted polynomial models are depicted as lines with color corresponding to genotype. Knockout females have signiﬁcantly smaller ovaries than wildtype
when controlling for age (quadratic regression p-value= 8.1 × 10−3). Gray hashed line demarcates rough onset of puberty in females. d Composition of
follicles differs signiﬁcantly between wildtype and knockout female ovaries, with signiﬁcantly fewer pre-ovulatory follicles and signiﬁcantly more atretic
follicles in knockout (Hotelling t-test p-value= 3.5 × 10−3). Center line=median; hinges= upper and lower quartiles; whiskers= 1.5 × interquartile range.
e Ovarian histology in a wildtype versus knockout female. Knockout ovaries were consistently enriched for foam cell macrophages, conﬁrmed by Oil Red O
stain in adjacent sections. We occasionally observed ovarian cysts in knockout females (asterisk). f Ovary from 336-day-old knockout showing extensive
involvement of foam cells occupying 40% of the tissue (left). High magniﬁcation of ovary section from same animal; top shows multinucleated appearance
of foam cells, bottom is Oil Red O stain of adjacent section (right). All scale bars= 100 μm. Source data are provided as a Source Data ﬁle
Table 1 Raw biometry and fecundity measurements from
Csmd1 mutant colony
WT KO
Ovary weight 0.057 [0.024−0.090] 0.028 [0.017−0.039]
Mammary weight 0.48 [0.35−0.61] 0.37 [0.26−0.48]
Testis weight 0.29 [0.24−0.34] 0.27 [0.25−0.29]
Maternal litter size 6.6 [5.4−7.8] 6.9 [5.7−8.1]
Paternal litter size 5.4 [3.4−7.4] 7.4 [6.6−8.2]
Mean values +/− 1.96 standard errors of the mean. All weights are the sum of bilateral
measurements per animal in grams. Litter size measurements are stratiﬁed by maternal and
paternal genotype and do not include individuals that failed to conceive (i.e. they only include
non-zero litter sizes)
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alleviate the morphological degeneration and fertility defects
observed in Csmd1 knockout mice. To test this prediction,
we generated colonies of C3−/− single KO mice and C3−/−
Csmd1−/− double KO mice. We did not observe any severely
deranged C3−/− testes or ovaries (Supplementary Fig. 8). Sur-
prisingly, we found no evidence of rescue of the Csmd1−/− single
KO phenotype in double KO males or females (Supplementary
Fig. 9). Instead, we observed an unmasked phenotype of more
severe histological degeneration in all DKO females, characterized
by far more extensive invasion of foam cell macrophages,
extensive pyknosis, and deformed follicles. We also observed loss
of cellularity in the mucosal layer of the oviduct (Supplementary
Fig. 9b). We monitored the fertility of 19 DKOs (10 males and 9
females) and, of these, only 4 (21%) produced progeny after at
least 3–7 months of mating (3 males and 1 female; Supplementary
Fig. 9, Supplementary Table 3). These extreme phenotypes are
not observed in Csmd1 or C3 single KOs46, suggesting that the
combined effect of Csmd1 and C3 on fertility is synergistic.
Discussion
We used a rare variant association approach to search for genes
that modulate both male and female gonadal function, and
identiﬁed the complement regulator CSMD1 to be reproducibly
associated across multiple patient cohorts and different classes of
genetic variation. Our study was powered to capture rare variants
of mild to moderate effect — that is, mutations that signiﬁcantly
increase risk of developing infertility, but still potentially segre-
gating in the population. Conversely, our study was poorly
powered to identify extremely rare/de novo, highly penetrant
infertility mutations (e.g. TEX11 (ref. 38), SYCE1 (refs. 38,47),
SPIDR48). We found that multiple types of genetic perturbations
of CSMD1 associate with infertility traits in humans, most
notably deletions within introns 1–3 of the gene. Intronic dele-
tions can affect gene function by altering splicing, RNA stability,
and transcriptional regulation, and recent work has shown that
such deletions tend to reduce transcript levels when they perturb
expression of their host gene, although upregulation is also pos-
sible49. All infertility-associated deletions found in this study fall
within 500 kb of 3 independent GWAS peaks for age at
menarche. In the GTEx atlas, we found that only two tissues show
signiﬁcant CSMD1 expression-associated quantitative trait loci
(eQTL): thyroid and testis50 (Supplementary Fig. 10). Although
the CSMD1 gene body spans over 2Mb of the genome, all of these
eQTL are clustered within a 390 kb window spanning introns 1
and 2. The 3 noncoding GWAS SNPs from Day et al.28 are not in
appreciable LD with the GTEx eQTL. We also screened
ENCODE51 for functional annotations in this region. Functional
summaries (e.g. chromHMM output) are not yet available for
testis, ovary or mammary gland; instead we used functional
summaries derived from 6 human cell lines and identiﬁed 4
consensus CTCF sites within the region (Supplementary Fig. 10).
We conclude that CSMD1 introns 1 and 2 likely harbor functional
elements that can inﬂuence gene expression in testis, but addi-
tional functional data are needed to map these elements, as well as
potential elements in ovary and mammary gland.
Furthermore, we found that rare protein-coding SNVs within
the CUB domains of CSMD1 are signiﬁcantly associated with age
at menopause. According to the Residual Variation Intolerance
Score (RVIS) only 0.169% of genes in the genome are more
intolerant to protein coding changes than CSMD1 (ref. 52).
Likewise, CSMD1 is massively depleted for rare loss-of-function
(LoF) variation in the gnomAD reference database53, with a pLI























Fig. 6 C3 and CSMD1 protein colocalize at the oocyte surface. a Spatial relationships between C3 and CSMD1 in developing follicles. C3 and CSMD1
immunoﬂuorescence of oocytes in developing follicles. In most follicles, C3 and CSMD1 colocalize at the oocyte plasma membrane with overlapping signal
(Colocalization, left panels). Occasionally the two signals separate and C3 is localized in a tight but distinct ring outside of CSMD1 (no colocalization, right
panels). b Spatial relationships between C3 and F4/80-positive macrophages in developing, atretic, and post-ovulatory follicles. F4/80
immunoﬂuorescence of adjacent follicles shows positive macrophage signal in corpus luteum, but not within developing follicles. C3 is localized to the
oocyte membrane, as well as in the follicular ﬂuid of the developing antrum (asterisk). Atretic follicles at different stages of degeneration (white arrows)
show varying levels of C3 and F4/80 expression. F4/80 can also be seen in a punctuated pattern along the stroma and thecal layers (white arrowheads).
C3 is also present in corpus luteum. Individual follicles are circumscribed by dashed lines. All scale bars= 50 μm. Source data are provided as a Source
Data ﬁle
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given the local increase in CSMD1 de novo SNV mutation
rate54,55, which is also corroborated by the substantial enrichment
of rare synonymous variation in CSMD1 (ref. 53). Altogether we
favor a LoF effect of CSMD1 mutations in human primary
gonadal dysfunction.
How do our mouse studies relate to the human genetic ﬁndings
and what are their limitations? We characterized a Csmd1 genetic
knockout construct that was not strictly identical to any of the
rare patient mutations found in our study. Further complicating
our interpretation of the mouse data is our ﬁnding that Csmd1
KO gonads display nonspeciﬁc and/or residual expression signal;
a phenomenon previously observed in Csmd1 KO brain36. Given
the exceptional intolerance of CSMD1 to LoF variation in
humans, we hypothesize that incomplete Csmd1 loss-of-function
is buffered by functional redundancy56 (e.g. from Csmd2 and
Csmd3)57, and that complete loss-of-function of Csmd1 would
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lead to much more severe and/or systemic phenotypes in both
humans and mice. A complete tissue-speciﬁc and/or inducible
loss-of-function knockout of Csmd1 could help to better disen-
tangle these potential effects but would be technically prohibitive
due to the size of the gene.
Despite these practical limitations, the mouse mutants pro-
vided an invaluable and previously undescribed functional link
between CSMD1 and reproductive function. Our human samples
were ascertained based on pathologic loss of germ cells, and/or
reduced reproductive lifespan. We observed heterogeneous
gonadal defects corresponding to reduced reproductive lifespan
and premature germ cell loss in both male and female Csmd1 KO
mice, and these phenotypes were unexpectedly exacerbated in
Csmd1−/−, C3−/− double KO mice. While we have neither
explicitly nor implicitly deﬁned the mechanism of CSMD1
mutations on gonadal function here, we have constructed a fra-
mework that implicates overzealous activation of the complement
pathway as a potential contributor to the pathophysiology of the
disease, due to the known molecular function of CSMD1 as a
complement inhibitor15, the spatiotemporal patterns of
complement-related proteins and cell types in the gonads, and the
excess complement deposition on Csmd1 KO testes.
While complement has a long-appreciated role in innate
immunity, it also plays a prominent role in the regulation of self
cells during normal postnatal development. A classic example of
this phenomenon is complement-mediated synaptic pruning in
the developing brain, a process that is under genetic inﬂuence and
can confer risk for disease when dysregulated20,58. Here, we have
reported abnormal post-natal development in Csmd1 knockout
animals for three additional tissues; we have observed comple-
ment and CSMD1 protein expression in all three tissues, and
previous work has shown that macrophages are essential for
proper development in all three tissues. A parsimonious model to
describe the set of defects we observe here is that macrophages
(and potentially other phagocytes such as Sertoli cells) regulate
and reﬁne developing cells in testis, ovaries, and mammary by
controlled deposition of complement onto their cell surface,
accompanied by subsequent phagocytosis.
Speciﬁcally, in the testis, increased C3 deposition in Csmd1
knockout taken in context of the known complement-inhibitory
function of CSMD1 (ref. 23) suggests that overzealous
complement-mediated phagocytosis of developing germ cells by
macrophages and/or Sertoli cells underlies at least part of the
testicular defects. C3 mRNA and protein are much more highly
expressed in the interstitial spermatogonial layer, which is phy-
sically sequestered from the lumenal aspect of the tubules by the
blood–testis barrier;59 Conversely, CSMD1 is largely expressed in
the adlumenal compartment (Fig. 2e, f). Spermatogonial fate is
closely tied to interstitial macrophages33, which are abundant in
the testis, express factors essential for spermatogonial differ-
entiation, and enter the tubules and phagocytose germ cells
during aging and disease60,61. Concerted apoptosis of differ-
entiating spermatogonial stem cells is a prominent and quanti-
tatively reproducible feature of normal spermatogenesis62. If
complement marks some targets of phagocytosis in the testis in
an analogous manner to that shown in the brain63, ectopic
complement activation across the blood–testis barrier may
inappropriately activate the apoptotic and phagocytic apparatus
in Csmd1 KO testes. Remarkably, TEP1 (a distant ortholog of C3)
has been shown to clear apoptotic germ cells in the mosquito
testis by this very process64
Macrophage activity in the ovary is very carefully regulated in
time and space during the estrous cycle. Prior to ovulation,
macrophages are excluded from the granulosa layer of follicles of
all types — except the atretic follicles, which are invaded by
macrophages and do not ovulate65–67. After ovulation, macro-
phages invade the ruptured follicle which undergoes apoptosis/
phagocytic luteolysis, forming the corpus luteum68. We showed
that CSMD1 is also highly expressed on oocytes of the developing
follicle, but not in the corpus luteum (Fig. 2d). CSMD1 loss of
function may allow for premature macrophage invasion of the
developing follicle, leading to excessive oocyte atresia, fewer
ovulations, and reduced probability of pregnancy (Fig. 5).
In addition to the gonads, CSMD1may also participate in post-
natal developmental processes across other tissue systems. We
have demonstrated a robust association between neonatal mor-
tality rate and maternal Csmd1 genotype status, with corre-
sponding reduction in the epithelial network of the maternal
mammary gland (Fig. 7). The mammary gland is a highly motile
network of branching epithelial tissue that advances and recedes
during different stages of post-natal development (i.e. puberty,
pregnancy, nursing, etc69.). The characteristic directionality of
mammary branching is conferred by polarized cell proliferation
and phagocytosis mediated by macrophage remodeling, especially
in anticipation of nursing70. Furthermore, multiple complement
and complement-regulatory components are robustly upregulated
during periods of apoptosis and phagocytosis in the mammary
tissue of multiple species including humans71,72, though the
functional signiﬁcance of this regulatory program is unknown.
Breast milk itself also suppresses complement activation73.
Finally, CSMD1 is expressed on the lumenal aspect of mammary
ducts and terminal end buds, where much of the pregnancy-
associated breast remodeling occurs15,74 (Fig. 7b). We observed a
reduction in mammary epithelial density, due to reduction in
Fig. 7 Csmd1 KO mothers have increased offspring mortality related to maternal nursing defects. a Scatterplot depicting number of pups surviving the
neonatal period versus live births, stratiﬁed by maternal Csmd1 genotype. Points that lie along the dashed line (slope= 1) represent litters with no neonatal
deaths. Maternal Csmd1 genotype is signiﬁcantly associated with surviving litter size (10.5% vs. 50.0% survival; Poisson regression p-value= 7.93 × 10−7).
Points deviate slightly from whole numbers for ease of visualization. b Immunoﬂuorescence shows CSMD1 expression in bifurcating mammary ducts and
bulbous terminal end buds. CSMD1 is expressed on both lumenal epithelial cells and myoepithelial cells throughout different stages of adult life. Expression
is lowest at puberty and increases during pregnancy, with the highest intensity during involution. Scale bars= 50 μm. c Higher magniﬁcation image of
CSMD1 expression in a myoepithelial cell (dashed lines, left) surrounding an alveolus during lactation and stromal cells (right). Scale bars= 50 μm.
d Whole-mount mammary glands of wildtype and knockout littermates show reduced epithelial network density (square brackets) in knockouts.
Scale bars= 5mm. e Knockout ducts demonstrate reduced number lateral branches (arrowheads). Scale bars= 500 μm. f Image analysis in age-matched
wildtype vs. knockout nongravid nulliparous adult mammary ducts. Knockout females have signiﬁcantly reduced number of branch points along the ducts
(JD, two-tailed t-test p-value < 0.05) and reduced number of end segments (EPD, two-tailed t-test p-value < 0.01). VPA= percent area occupied by ducts.
JD= branchpoint density per mm. TVL= sum of Euclidean distances among adjacent branchpoints. AVL= average Euclidean distance between adjacent
branch points. EPD= number of duct end points normalized by total vessel length. Center line=median; hinges= upper and lower quartiles;
whiskers= 1.5 × interquartile range. g C3 and CSMD1 colocalize in mammary. Immunoﬂuorescence shows abundant C3 signal within mammary ducts with
empty lumina (left) and ducts with cells in the lumen (middle). C3 signal is also present in some CSMD1-positive stromal cells (right). Scale bars= 20 μm.
Source data are provided as a Source Data ﬁle
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secondary or tertiary branch points, whose normal geneses are
governed by multiple upregulatory and downregulatory chemo-
tactic signals in concert with physical interaction with phagocytic
cells (i.e. macrophages)75.
The unmasking of a more severe phenotype in C3/Csmd1 DKO
mice is an unexpected but previously documented signature of
complement-mediated disease. For example, double knockout of
complement factor H (CFH) and factor P (CFP) unexpectedly
converts mild C3 glomerulonephritis to lethal C3 glomerulone-
phritis in mice76. Similarly, CFH/C3 DKO unexpectedly unmasks
a more severe form of age-related macular degeneration in
mice77. Multiple explanations for this phenomenon have been set
forth, including a dual role of C3, differences between ﬂuid-phase
and local C3 activation, and context-speciﬁc C3 gain-of-function.
Finally, we cannot exclude the possibility of primary defects
outside of the gonads causing pathology in our double knockouts
(e.g. altered hemostasis, central defects, etc.). More extensive
mutation constructs including conditional knockouts and allelic
series may help to distinguish among these scenarios.
Altogether, our human genetic and model organism ﬁndings
lend support to a role of CSMD1 across multiple tissue types, and
unveil a potential role for the complement system in postnatal
developmental processes across multiple tissues in the body.
When interpreted in context of existing observations from
mammalian brain and other model organisms, we predict that
macrophage mediated complement activity on self cells is a
normal and highly controlled process in many developmental
systems in metazoans. Furthermore, a wealth of literature shows
that genetic dysregulation of complement and complement-
regulating factors is a core feature of several heritable diseases
beyond infertility;20,58,78–87; we therefore consider CSMD1 to also
be a reasonable candidate for many of these diseases. Our work
highlights the need for deeper investigation into the role of
immune system components in reproductive tissues, and the
opportunities that such work can have to illuminate and connect
common biological processes that produce disease in more
complex contexts across the body.
Methods
Human patient populations. All human genetic studies were reviewed and
approved by the Institutional Review Board of Washington University in St. Louis,
under protocol numbers #201107177 and #201109261 and all participants provided
informed consent. Male idiopathic infertility cases were clinically ascertained and
pre-screened for chromosome Y deletions and compared against normospermic
controls13,14. WHI-SHARe. To create an analogous case-control cohort of female
gonadal dysfunction, we turned to the SNP Health Association Resource (SHARe)88.
We constructed early idiopathic case and control deﬁnitions from the dense
reproductive phenotype data collected on each subject. A self-reported age of
menopause before 40 years was used as the only case inclusion criterion. Case
exclusion criteria were oophorectomy prior to age 40, a diagnosis of lupus or
rheumatoid disease, and a “yes” answer to the question “Did a doctor ever say that
you had cancer, a malignant growth, or tumor?”. Smoking history, which is a known
factor inﬂuencing ovarian reserve, was controlled for during the analysis of
genetic data.
UK Biobank. This research has been conducted using the UK Biobank Resource
under Application Number ‘17085’. We generated a table of phenotype data for
constructing early idiopathic menopause case and control labels using controlled-
access data from the UK Biobank. Exclusion criteria for the study were: withdrawn
consent, poor heterozygosity or missingness as deﬁned by the UK Biobank; >10
relatives in the UK Biobank cohort; not used in autosome phasing, apparent sex
chromosome aneuploidy; mismatch between genetic and self-reported sex; ever
smoker; any self-reported non-Caucasian ancestry; oophorectomy prior to age 40;
prior diagnosis of rheumatoid arthritis, lupus, or pelvic cancer; mismatch between
self-reported ethnicity or age at menopause among three assessments; SNP array
call rate <98%. In the case of pairs of 2nd degree relatives or closer, the one
individual with the lower SNP-call rate was dropped. The inclusion criteria for POI
case status were self-reported age of menopause <40 years old, and all remaining
individuals in the cohort (after exclusions mentioned above) were used as controls.
Mouse colony breeding. We acquired a constitutive Csmd1 knockout mouse (Mus
musculus) on a mixed 129SvEvBrd:C57BL/6 background from the UC Davis
KOMP Repository (Project ID CSD118901)89. A 1.086 kb deletion encompassing
Csmd1 exon 1 and part of intron 1 were replaced with a lacZ/neomycin cassette.
Deletion of this segment was conﬁrmed with Southern blot and PCR. Due to the
extreme size of Csmd1 (1.6 Mb), we also analyzed RNA seq data across all 70 exons
in knockout testes and ovaries. In ovaries, knockout read counts relative to wild-
type are suppressed across all 70 exons. In testes, knockout read counts relative to
wildtype are broadly suppressed across exons 1-57 and upregulated from exons 58-
70. The amino acid coding portion of these upregulated exons range in size from
45 bp to 180 bp. The translational viability of these fragments is unknown. All
littermate tissue comparisons in this study (described below) were generated from
damheterozygous × sireheterzygous crossings from this original colony. Next, to eliminate
variance in phenotype explained by variance in background genotype (if any), we
serially backcrossed the Csmd1 mutation onto a constant C57BL/6 background for
5 generations. From this F5 backcross generation we performed a damheterozygous ×
sireheterozygous cross from this to create wildtype and knockout littermates, and
performed analogous histology and immunoﬂuorescence experiments as with the
original colony (described below; Supplementary Fig. 5e). We performed micro-
satellite genotyping of these littermates to estimate the C57BL/6 background after
backcrossing (Washington University Rheumatic Disease Core). We estimated the
F5 proportion of C57BL/6 ancestry of 0.91 (95% CI [0.89−0.93]). For DKO
experiments, we introgressed a C3 mutant line90 until we achieved Csmd1/C3 DKO
mice. All animal experiments were performed in compliance with the regulations
of the Animal Studies Committee at Washington University in St. Louis under
protocols #20120244 and #20160089.
CNV and SNV discovery. Array data for the Women’s Health Initiative SHARe
cohort were downloaded from the NCBI Database of Genotypes and Phenotypes
(dbGAP accession number phg0000g1.v2). SHARe samples were genotyped on the
Affymetrix 6.0 platform. We created a high-quality set of CNV calls for all cohorts
using our own internal pipelines. SHARe samples were processed with Affy6CNV
(a wrapper that we wrote for the Birdsuite package91) for data processing and QC.
We obtained raw SNP array data from the UK Biobank and performed single
sample CNV discovery using PennCNV92. Individuals with >200 CNV calls were
dropped. CNV calls with PennCNV quality score >30 were retained, and adjacent
CNVs in the same sample were merged. All qPCR validation of CSMD1 CNV calls
were performed on Applied Biosystems TaqMan assay # Hs0367742_cn (catalog
#4400291). We used Human RNase P for the reference assay (catalog #4403326).
We used standard Applied Biosystems TaqMan protocols in 10 µL reaction
volumes. We generated 4 to 8 technical replicates for each sample in a 384 well
plate. PCR conditions were as follows: 50 °C for 2 min, 95 °C for 10 min, then 40
cycles of 95 °C for 15 s and 60 °C for 1 min. TaqMan copy number was estimated
using the CopyCaller software and compared to PennCNV copy number estimates.
Exome sequencing was performed on a subset of the WHI subjects as part of the
Women’s Health Initiative Sequencing Project (WHISP); all available WHISP
BAM ﬁles were downloaded from the NCBI Database of Genotypes and
Phenotypes (dbGaP accession phs000200.v10.p3.c1 and phs000200.v10.p3.c2)93.
Genotypes were recalled, jointly, from 1668 WHI BAM ﬁles using Haplotype
Caller, recalibrated and cleaned according to GATK best practices using GATK-
3.2.2.
Association testing. CNVs. Rare CNVs were associated with case-control status
using generalized linear models. For the SHARe association analysis, we included
the top 10 ancestry eigenvectors (calculated from the full SHARe genotype matrix)
and smoking history as covariates. For the UK BioBank association analyses, and
we included as covariates BMI, smoking history (or individuals with any history of
smoking were excluded, where noted) and the top 10 ancestry eigenvectors cal-
culated from the full UK Biobank SNP genotype matrix.
In addition to idiopathic early menopause (deﬁned above in Human patient
populations), we performed association testing for the following 4 traits for UKBB
subjects (Unique Data Identiﬁer codes in parentheses): Length of menstrual cycle
(3710), Number of live births (2734), Age at last live birth (2764), all-cause female
infertility IC10 code (N97).
SNVs. We tested for an association between rare SNVs in CSMD1 and age at
menopause in the WHI samples using the Sequence Kernel Association Test
(SKAT)94, weighting each variant with the Combined Annotation Dependent
Depletion (CADD) value95. Five ancestry eigenvectors and smoking history were
included as covariates; signiﬁcance was evaluated using bootstrapping with
5000 samples.
Testes dissociation and cell sorting and RNA extraction. We adapted existing
methods for dissociation and germ cell puriﬁcation96 which we describe below.
Sexually mature (40 ± 1 days old), male mice were sacriﬁced, and their testes were
decapsulated and homogenized in a 1× MEM solution (Gibco 11430-030) con-
taining 120 U/mL Type I Collagenase (Worthington Biochemical LS004194) and
1 mg/mL DNAse I (Roche 10104159001), and agitated for 15 min. 1× MEM was
replaced and added with 50 mg/mL Trypsin (Worthington Biochemical 54J15037)
and 1 mg/mL DNAse I and agitated for 15 minutes, then mechanically homo-
genized for 3 min. 50 mg/mL Trypsin and 1 mg/mL DNAse I were added and
agitated again for 15 min. We added 0.4 mL heat inactivated Fetal Bovine Serum
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(Sigma F1051), 5 μL Hoescht 33342 (Life Technologies H3570), and 1 mg/mL
DNAse I, and agitated for 15 minutes. Individual cells were dissociated by pipetting
sequentially through two 40 μm cell strainers (Falcon 352340). For each individual
mouse, one dissociated testis was used for whole tissue RNA extraction and
sequencing, and the other testis was used for germ cell puriﬁcation, RNA extrac-
tion, and sequencing. All dissociation steps were performed at 33 °C. Dissociated
testes were sorted on a modiﬁed MoFlo cytometer (Beckman Coulter) at the
Washington University Siteman Flow Cytometry Core using a krypton-ion laser97.
Cells that are stained with Hoechst can be clustered in two wavelengths: (i) blue
ﬂuorescence, which is informative of DNA content, and (ii) red ﬂuorescence, which
is informative about chromatin state and Hoechst efﬂux from the cell. Our gating
strategy is graphically summarized in Supplementary Fig. 3. Based on these
parameters, we separated homogenized testes suspensions into four puriﬁed
populations: (i) spermatogonia, (ii) primary spermatocytes, (iii) secondary sper-
matocytes, and (iv) spermatids. These separated populations were collected and
RNA extraction performed on them. RNA from whole testes was extracted with the
RNeasy Plus Mini Kit (Qiagen 74134), and RNA from FACS-puriﬁed germ cell
populations was extracted with the RNeasy Plus Micro Kit (Qiagen 74034).
RNA-seq. Whole testis, whole ovaries, and puriﬁed male germ cell subpopulations
were obtained from wildtype and Csmd1 null siblings (summarized in Supple-
mentary Data 3). We extracted polyadenylated mRNAs from each tissue/cell type
and converted these into RNA-seq libraries. Three biological replicates of each
tissue or cell type were sequenced with a 2 × 101 bp paired-end protocol. Reads
were mapped to Ensembl Mus musculus reference R72 and transcript expression
levels were summarized as reads-per-kb of exon per million-mapped reads
(RPKM) using the TopHat2 package98. RPKMs were adjusted for batch effects and
cryptic covariates using PEER99, quantile normalized, and then the R package
poissonSeq was used for differential expression analyses100.
Immunostaining and imaging. Testes and ovaries were dissected, ﬁxed in 4%
paraformaldehyde (Electron Microscopy Sciences), and embedded in parafﬁn. We
baked 5 μm sections at 60 °C for 1 h, deparafﬁnized in Xylenes, and rehydrated into
PBS (Corning). Antigen retrieval was done in boiling citrate buffer (10 mM sodium
citrate, 0.05% Tween-20, pH 6.0) for 20 min. Sections were blocked in PBS con-
taining 0.2% Triton X-100 and 5% normal donkey serum (Jackson Laboratories)
for 1 h at room temperature and then incubated with primary antibodies diluted in
blocking solution over night at 4 °C. After washing with PBS-Tx (PBS containing
0.2% Triton X-100), they were incubated with ﬂuorescent secondary antibodies in
blocking solution for 1 h at room temperature, washed with PBS-Tx, and treated
with 0.2% Sudan Black in 70% EtOH for 10 min, followed by PBS washes. The
sections were then counterstained with Hoechst dye 33342 diluted 1:500 in PBS for
5 min, washed once with PBS-Tx for 2 min and then with PBS, and mounted in
ProLong Diamond anti-fade mounting medium (Molecular Probes). Imaging was
done on an Olympus LSM700 confocal microscope using Zen software, and images
were processed using Photoshop CS5 (Adobe). Antibodies used were gt α-CSMD1
N20 (Santa Cruz Biotechnology sc-68280 1:100), rb α-mouse vasa homolog (MVH)
(Abcam 13840, 1:1,000), donkey α-gt CF594 (Biotium #20116 1:300), and donkey
α-rb Alexa488 (Life Technologies #A-21206 1:300), rb α-β-gal (Cappel #55976
1:333), rat F4/80 BM8 (Santa Cruz Biotechnology sc-52664 1:50), donkey α-rat
Alexa488 (Life Technologies #A-21208 1:300), rb α-C3 (Abcam 200999, 1:2000),
and gt α-rb Alexa568 (Life Technologies #A-11011, 1:300). Testes were dec-
apsulated in 1x PBS and the tubules were gently teased apart and ﬁxed in 4%
paraformaldehyde in 1× PBS for 2 h at 4 °C. After washing with PBS and blocking
in PBS containing 0.2% Triton X-100 and 5% normal donkey serum for 1.5 h at
room temperature, they were incubated in primary antibodies overnight at 4 °C in
blocking solution and processed as the cross-sectional IF experiments were
described above33. For immunohistochemistry, 5 μm parafﬁn sections were treated
as above, except the secondary antibody was biotin-coupled horse α-goat (Vector
Laboratories, BA-9500, 1:200), and detection was done using the Vectastain Elite
ABC kit (Vector Laboratories, PK-6100) and DAB Peroxidase Substrate kit (Vector
Laboratories SK-4100) per the manufacturer’s instructions. Sections were coun-
terstained with hematoxylin, mounted in Cytoseal Xyl (Thermo Scientiﬁc), and
imaged on a Zeiss Axioplan 2 microscope equipped with an Olympus DP71 camera
and DP software. For X-gal staining, whole tissues were ﬁxed in 4% PFA in PBS for
2 h, washed with PBS, and stained in X-gal (GoldBio #X4281C1) overnight101.
Tissues were embedded in parafﬁn, sectioned at 5 μm, and counterstained with
hematoxylin.
Histology. Freshly-dissected gonads were ﬁxed under agitation in Modiﬁed
Davidson’s ﬁxative (Electron Microscopy Sciences 64133-50) for 24 h and Bouin’s
ﬁxative (Electron Microscopy Sciences 26367-01) for 24 h. Fixed tissues were
embedded in parafﬁn and sectioned at 5 μm. Sectioned tissues were stained with
hematoxylin and counter-stained with either Periodic acid-Schiff reagent102 or
eosin. Stained testes from 65 individual mice of known age and genotype (12
wildtype, 53 knockout) were provided to a single mouse pathologist in a blinded
fashion. All samples received a score of 0 (no damage), 1 (mild damage), or 2
(severe damage) (see Supplementary Fig. 5a for exemplars). In order to estimate the
effect of genotype on score, we ﬁt a linear analysis of variance model:
yijk ¼ μþ αi þ βj þ εijk ð1Þ
where yijk is the damage score for individual k, μ average damage score across all
animals, αi is the effect of genotype i, βj is the effect of age j, and εijk is the random
error associated with the kth observation.
Germ cell quantiﬁcation. We performed immunoﬂuorescence as described above
on a pair of 34 day old male littermates (the same individuals as seen in Supple-
mentary Fig. 5c) using TRA98 antibody (Abcam ab82527 1:200). We generated
count data for total cells (ﬁltering based on size and shape), and for TRA98-positive
cells (ﬁltering based on green ﬂuorescence) using the ImageJ software package. In
order to estimate the effect of genotype on TRA98 cell count, we ﬁt the following
model:
ln yið Þ ¼ β0 þ β1X1i þ β2X2i þ εi ð2Þ
Where yi is the TRA98-positive count in image i, and X1 is the genotype (Csmd1
wildtype versus knockout), and X2 is the total cell count. εi is the nuisance variable
for image i.
Gonad size analysis. We sacriﬁced 229 adult mice (106 males and 123 females),
and measured body weights and bilateral gonad weights at necropsy. For males,
mean body weight was 37.1 g, mean testes weight was 273 mg, and mean age was
201 days. For females, mean body weight was 31.3 g, mean ovary weight was 32 mg,
and mean age was 234 days. In order to estimate the effect of genotype on gonad
weight, we ﬁt the following linear model:
yi ¼ β0 þ β1X1i þ β2X2i þ β3X3i þ εi ð3Þ
Where yi is the gonad weight in individual i, and X1i, X2i, and X3i are the genotype,
age, and body weight of individual i, respectively. εi is the nuisance variable for
individual i.
Quantifying daily sperm production. Daily sperm production (DSP) was esti-
mated using the Triton-X 100 nuclear solubilization method103. Frozen testes were
quickly thawed at room temperature and approximately half was used to estimate
DSP. Sample weight was registered for full testis and tissue fragment used for the
assay. To burst all cells, except for spermatid heads, the tissue was sonicated in DSP
buffer (0.9% NaCl, 0.01% sodium azide (SAZ), 0.05% Trition-X-100) using short
pulses (3 × 10 s at 30% amplitude). Sperm heads were then collected by cen-
trifugation (10 min at 500×g) and used in 1:1 dilutions with 0.4% Trypan Blue for
estimation of cell density per homogenate in a hemacytometer. These values were
then used to estimate the total number of spermatids per testis [number spermatids
in homogenate divided by sample weight (g) and multiplied by the full testis weight
(g)]. In mouse spermiogenesis, steps 14–16 take 4.84 days (developing spermatids),
therefore, DSP was calculated by dividing the total number of spermatids in one
testis per 4.84 days.
Follicle count analysis. We sacriﬁced 15 sexually mature female mice, of which 10
were wildtype and 5 were knockout genotypes. Bilateral ovaries were ﬁxed, sec-
tioned to 5 μm, and stained with H&E. We identiﬁed primordial follicles, primary
follicles, secondary follicles, early antral follicles, antral follicles, preovulatory fol-
licles, atretic follicles, and corpora lutea across each section based on histologic
appearance104. In order to estimate the effect of genotype on gonad weight, we ﬁt
the following model:
ln yið Þ ¼ β0 þ β1X1i þ β2X2i þ εi ð4Þ
Where yi is the number of total oocytes in bilateral ovaries of individual i, and X1i
and X2i are genotype and age, respectively. εi is the nuisance variable for individual i.
Breeding time analysis. We compiled comprehensive husbandry information
over a period of greater than 1 year corresponding to 151 litters born representing
all possible Csmd1 wildtype, heterozygote, and knockout sire/dam breeding com-
binations. We calculated the number of days between ﬁrst sire/dam co-habitation
and birth of each litter. Next we subtracted an estimated C57BL/6 gestation time of
19 days105 to estimate time to conception. We also calculated parental ages at
conception. All density plots depicted in Fig. 5b reﬂect estimated time to con-
ception for all 151 litters. In order to estimate the effect of maternal genotype on
mating success, we controlled for paternal genotype by including wildtype sires
only. We then ﬁt the following linear model:
yi ¼ β0 þ β1X1i þ β2X2i þ β3X3i þ εi ð5Þ
Where yi is the estimated time to conception for mating pair i, X1i is maternal
genotype (wildtype, heterozygote, or knockout), X2i is maternal age at conception,
and X3i is paternal age at conception. εi is the nuisance variable.
Litter size analysis. We bred 44 females (8 wildtype, 27 heterozygote, and 9
homozygote) with 41 males (4 wildtype, 26 heterozygote, and 11 homozygote) over
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a period of 10 months to produce 99 litters, totaling 688 live births. All 9 parental
genotype permutations [wtdam × wtsire, wtdam × hetsire … homdam × homsire] were
represented multiple times (excepting hetdam × wtsire). We counted deaths in during
the neonatal period (deﬁned as 1–10 days by convention, although the vast
majority of deaths occurred within 24–48 h) and subtracted from the live birth total
to obtain the ﬁnal number of surviving pups (550 total). Next, we stratiﬁed each
litter by maternal and paternal genotype status (Csmd1 wildtype or heterozygous
versus knockout) and ﬁt the following model:
ln yið Þ ¼ β0 þ β1X1i þ β2X2i þ εi ð6Þ
Where yi is the number of surviving pups in litter i, and X1i and X2i are the
maternal and paternal genotypes, respectively. εi is the nuisance variable for litter i.
Mammary gland whole-mount analysis. Female littermates were collected at four
developmental time points: (i) pre-pubescent (<30 days of age); (ii) adult virgins;
(iii) mid-pregnancy (estimated 14 days after copulation); (iv) post-weaning (7 days
after weaning pups from mother’s nursing). Freshly-dissected whole inguinal
mammary glands were ﬁxed overnight in Carnoy’s solution (60% ethanol, 30%
chloroform, 10% glacial acetic acid). Fixed tissues were washed and rehydrated in
ethanol and water and stained in Carmine alum histological stain (0.5% Aluminum
potassium sulfate, 0.2% Carmine) for 48 h. Stained tissues were dehydrated with
increasing concentrations of ethanol and stored in xylene to clear lipids for 48 h.
Finally, tissues were ﬂattened mechanically and suspended in pure methyl salicylate
prior to imaging. Due to the large size of whole mammary tissues, overlapping
ﬁelds of view were captured and stitched together using the “Photomerge” function
in Adobe Photoshop. Gaps in the backdrop of the merged images were ﬁlled using
the “Content aware ﬁll” function in Adobe Photoshop— if and only if the gaps did
not overlap any portion of the tissue proper. All original images are available on the
Conrad Lab website. To perform statistical comparison of duct morphology
between genotypes, measurements of mammary gland ducts were derived from
images using AngioTool64 v0.6a106. First, a skeleton representation of the bran-
ched duct structure is generated from the input image, which is then used to
compute a variety of morphological and spatial parameters for branching char-
acterization. Since this software detects the branches by contrast on a black
background, the images of whole mount mammary glands of adult mice were
transformed into a compatible input using ImageJ 1.51n.
Hormone measurements. We collected serum from 9 males (4 wildtype versus 5
knockout; mean age= 103 days) and 16 females in the proestrous stage (7 wildtype
versus 9 knockout; mean age= 96 days) via submandibular collection. Each
wildtype individual was matched with ≥1 knockout littermate. Female estrous cycle
was determined ﬁrst by external inspection of the vaginal opening, then by vaginal
cytology107. Vaginal swabs were collected, transferred to a glass slide, and inspected
under light microscopy. Proestrus, estrus, metestrus, and diestrus staging was then
classiﬁed based on the relative counts of leukocytes, nucleated epithelial cells, and
corniﬁed epithelial cells. Only conﬁrmed proestrous females were selected for blood
draws and hormone measurements. All blood was drawn at approximately the
same time of day, clotted for 90 min at room temperature, and centrifuged at
2000×g for 15 min. Samples were stored at −20 °C prior to hormone measure-
ments. Male samples were quantiﬁed for LH/FSH (EMD Millipore) and testos-
terone (Immuno-Biological Laboratories Inc), and female samples were quantiﬁed
for LH/FSH and estradiol (CALBIOTECH) by the University of Virginia Ligand
Assay and Analysis Core.
C3 deposition assay. Testes obtained post-dissection from Csmd1 knockout and
wild-type mice were decapsulated and washed in 1× PBS before mincing. Minced
tissue was subjected to enzymatic dissociation as described above. The crude cell
preparation thus obtained was treated with ACK buffer (Life Technologies) for
5 min at room temperature to lyse erythrocytes present if any in the cell pre-
paration. The isolated cells were incubated in α-C3 (B9) primary antibody (Santa
Cruz Biotechnology sc-28294, 1:100) diluted in FACS buffer (1× PBS, 5%FBS, 0.1%
Sodium azide) along with 10% Fc block (to minimize non-speciﬁc binding and
background ﬂuorescence) for 45 min at room temperature, followed by gt α-mouse
Alexa488 (Abcam #A11029 1:250) incubation of 90 mins at RT in the dark with 3
washes of ice cold FACS buffer after each antibody incubation. Flow cytometry was
performed with an Accuri C6 cytometer (BD Biosciences).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Human sample data are from WHI-SHARe (dbGaP Study Accession phs000386.v7.p3),
WHISP (dbGaP Study Accession phs000281.v6.p3), UK Biobank (www.ukbiobank.ac.uk),
and GEMINI (www.gemini.conradlab.org) and can be obtained upon application.
GTEx data were viewed through www.gtexportal.org and ENCODE data were viewed in
the UCSC genome browser (genome.ucsc.edu). RNA-seq data generated in this study
have been submitted to the Gene Expression Omnibus accession number (GSE136769).
We further provide processed RNA-seq RPKM information for all samples as
Supplementary Data. A reporting summary for this Article is available as a Supplementary
Information ﬁle. The source data underlying Figs. 1–5, 7 and Supplementary Figs. 1, 3, 4, 6,
and 9 are provided as a Source Data ﬁle. Additional information is available upon request.
Code availability
Scripts used to perform data analysis are available upon request.
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